IP Lab Ventures
Status
ACTIVE
Global HQ
Prague, Czech Republic
Countries of investment
- Czech Republic
- Germany
Investment stages
- Pre-Seed
- Seed
- Series A
Industries
- Deep Tech
- AI
- Robotics
- Biotechnology
- Life Sciences
- MedTech
- Climate Tech
- Quantum Computing
About
IP Lab Ventures is a Prague-based venture firm investing in university and research spin-offs. Its Fund I is targeting $58M, with about $31M committed by the EIF. Their investments are concentrated in the Czech Republic, with a portfolio project in Germany, and the firm covers the wider Central and Eastern European region in its mandate. The fund is aimed at deep tech companies that originate in academic labs.
IP Lab Ventures is a Prague-based venture firm investing in university and research spin-offs. Its Fund I is targeting $58M, with about $31M committed by the EIF. Their investments are concentrated in the Czech Republic, with a portfolio project in Germany, and the firm covers the wider Central and Eastern European region in its mandate. The fund is aimed at deep tech companies that originate in academic labs.
Investment Thesis
IP Lab Ventures is an early-stage venture firm commercializing science from universities and research institutes, from pre-seed to Series A. Their core thesis is that technology transfer is an underused source of deep tech companies in the Czech Republic and wider Central and Eastern Europe, and that spin-offs need both early capital and commercialization support. What makes IP Lab unique is that its Fund I is Czechia’s first technology transfer fund, backed by about $31M from the EIF through the Czech recovery fund of funds.
Manager's Experience
Led by three General Partners, Filip Fingl (platform and venture leadership), Jiří Navrátil (science, IP and tech transfer) and Andrew Hladký (operations, finance and transactions), with Jan Krabec as Legal Counsel. The team incubates and co-founds companies from university and research IP, including Atomiver, MendelFOLD, Preagon Biotech, GWN, AMADTEUS and Biorea, ahead of a formal fund close. Builds deep tech and life science companies out of IP.
Team
Filip Fingl - General Partner (Platform & Venture Leadership)
Jiří Navrátil - General Partner (Science
IP & Tech Transfer)
Andrew Hladký - General Partner (Operations
Finance & Transactions)
Jan Krabec - Legal Counsel (Fund & Transaction Structuring)
Portfolio
Atomiver
MendelFOLD
Preagon Biotech
GWN
AMADTEUS
Biorea